-
If it seems as if your hospital takes two steps forward and one back when trying to conquer healthcare-associated infection rates, you arent alone.
-
Every few months, another big headline is splashed across the mainstream media, touting the top 100 hospitals, or the best cancer doctors, or your citys number-one neurologist. But what is missing from these stories is the fact that often, a facility or physician can rank in different places on different lists fabulous on one, middling on another.
-
Next seasons trivalent influenza vaccines will contain the same strains as this years vaccine but its still important to get the annual flu vaccine, according to the Centers for Disease Control and Prevention.
-
Hospital intensive care units (ICUs) in the U.S. report a high level of infection prevention policies in place, but the numbers fall off sharply when actual adherence to the interventions are factored in, researchers report.
-
A growing number of clinics around the world are advertising therapeutic applications for stem cell treatments that have not been subjected to well-controlled trials.
-
Data on physicians prescribing is routinely purchased from pharmacies, with physicians identified through information purchased from the American Medical Association.
-
There is a growing focus on identifying a core set of quality metrics that can be used to improve both palliative and end-of-life care.
-
Comparative effectiveness research (CER) has the potential to improve outcomes and lower costs, but one key ethical concern is how to best convey to patients that they are participating in research.
-
While the vast majority of gamete donations are made anonymously, a growing number of countries are enacting laws allowing children access to identifying information about their gamete donor.
-
The Affordable Care Act invested significantly in comparative effectiveness research (CER), but at the same time, states that no decisions coming out of CER should determine what treatments are covered by insurers, notes Norman Daniels, PhD, professor of ethics and population health at Harvard School of Public Health in Boston, MA.
